LifeStance Health Group (LFST) closed the last trading session at $5.84, gaining 3.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $8.14 indicates a 39.4% upside potential. The average comprises seven short-term price targets ranging from a low of $6 to a high of $10, with a standard deviation of $1.46. While the lowest estimate indicates an increase of 2.7% from the current pri ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Common Stock, par value $0.01 per share LFST The Nasdaq Stock Market LLC FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40478 | --- | --- | |------------------------------------ ...

LifeStance Health Group, Inc. (NASDAQ:LFST) Q2 2024 Earnings Conference Call August 8, 2024 8:30 AM ET Company Participants Monica Prokocki - Vice President of Investor Relations Ken Burdick - Chief Executive Officer Dave Bourdon - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Lisa Gill - JPMorgan Jack Senft - William Blair Dylan Finley - UBS Jack Slevin - Jefferies Stephanie Davis - Barclays Operator Thank you for standing by. My name is Jermanie, and I will be your ...

| --- | --- | |-------------|-------| | | | | | | | | | | | | | Reimagining | | Forward-Looking Statements DISCLAIMERS Cautionary Note Regarding Forward-Looking Statements This presentation and related oral statements, including during any question and answer portion of the presentation, contain forward-looking statements about LifeStance Health Group, Inc. and its subsidiaries ("LifeStance") and the industry in which LifeStance operates, including statements regarding: full-year and third quarter guidance ...

LifeStance Health Group (LFST) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.13 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 14.29%. A quarter ago, it was expected that this outpatient mental health services provider would post a loss of $0.09 per share when it actually produced a loss of $0.06, delivering a surprise of 33.33%. Over the ...

Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Finance & Investor Relations 602-767-2100 investor.relations@lifestance.com LifeStance Reports Second Quarter 2024 Results SCOTTSDALE, Ariz. – August 8, 2024 – LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the second quarter ended June 30, 2024. (All results compared to prior-year comparative period, unless otherwise noted) Q2 2024 Highlig ...

Shares of LifeStance Health Group (LFST) have gained 13.7% over the past four weeks to close the last trading session at $5.58, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $8.64 indicates a potential upside of 54.8%. The mean estimate comprises seven short-term price targets with a standard deviation of $0.94. While the lowest estimate of $7 indicates a 25.5% increase from t ...

FOCUS combines a precision blend of citicoline, tyrosine and pure lion's mane mushroom to deliver superior TORONTO, July 26, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, is pleased to announce that its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. ("Mikra") is on track building out a ...

LifeStance Health Group (LFST) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street anal ...

TORONTO, July 19, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF) a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, today announced that it has closed a non-brokered private placement (the "Offering") of secured convertible debentures (the "Debentures") for aggregate gross proceeds to the Company of $450,000 ("Principal Amount"). The Company inte ...